Get 15% Off on World Health Day Flash Sale Get 15% Off on World Health Day Flash Sale


Harnessing Your Body's Own Chemistry to Treat Ovarian Cancer

Researchers have discovered that a low dose of the opioid antagonist naltrexone (LDN) can have an extraordinarily potent antitumor effect on human ovarian cancer in tissue culture.

The discovery provides new insights into the pathogenesis and treatment of ovarian neoplasia, which is the 4th leading cause of cancer-related mortality among U.S. women. The strategy of using LDN therapy to repress cancer was first reported over 30 years ago. Naltrexone causes an elevation in your body's own opioids and opioid receptors.

Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access